Drug intelligence / Profile preview

caffeic acid phenethyl ester

Development stage
Phase 1
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical, Intraperitoneal, Intravenous
01

Overview

Caffeic acid phenethyl ester (CAPE) is a natural polyphenolic compound, specifically the ester of caffeic acid and phenethyl alcohol. It is a major bioactive component of propolis, the resinous substance produced by honeybees. CAPE exhibits a wide range of biological activities including potent antioxidant, anti-inflammatory, immunomodulatory, anticarcinogenic, antiviral, and cytoprotective effects. Mechanistically, it acts as an inhibitor of nuclear factor kappa B (NF-κB), suppresses p70S6K/Akt signaling pathways, inhibits 5-lipoxygenase and HIV-1 integrase enzymes, and modulates various cellular signal transduction processes. In preclinical studies and in vitro models it has shown selective cytotoxicity toward cancer cells while protecting normal tissues from oxidative stress or chemotherapy-induced damage[2][3][5][6][9][10]. Despite extensive research on its pharmacological properties in animal models and cell cultures—including protective effects against ischemia-reperfusion injury—its clinical significance in humans remains unproven.

Other names
phenethyl caffeatephenyl caffeatecaffeic acid phenyl ester
02

Targets

NF-κBALOX12 (Arachidonate 12-lipoxygenase, 12S type)Integrase allosteric pocket (HIV)

Beyond the preview

Go deeper on caffeic acid phenethyl ester.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on caffeic acid phenethyl ester.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call